Press release
In-Depth Examination of Segments, Industry Trends, and Key Players in the Chemotherapy Market
Chemotherapy Market
Anticipated Growth Trajectory of the Chemotherapy Market by 2030
The chemotherapy market is projected to reach a valuation of $68.44 billion by 2030, advancing at a compound annual growth rate (CAGR) of 13.0%. This strong expansion is fueled by the rise of precision medicine, the development of targeted therapies, greater awareness and acceptance of home-based chemotherapy, integration of digital health technologies, and increased use of combination drug therapies. Key trends expected to drive the market include personalized chemotherapy plans, the growing adoption of oral chemotherapy options, innovations in combination therapies, home delivery of chemotherapy treatments, and advances in infusion device technologies.
Download a free sample of the chemotherapy market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Prominent Companies Leading the Chemotherapy Market
Several major players dominate the chemotherapy space, including globally recognized pharmaceutical and biotech firms such as GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., and Sanofi SA. Other notable companies include Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., and Verastem Inc.
Strategic Acquisition Enhancing AbbVie's Oncology Portfolio
In February 2024, AbbVie, a US-based biopharmaceutical company, completed its acquisition of ImmunoGen for $10.1 billion. This strategic purchase is expected to strengthen AbbVie's oncology offerings by incorporating ImmunoGen's innovative antibody-drug conjugate technology. With this move, AbbVie aims to enhance its capabilities in developing advanced chemotherapy treatments for a variety of cancers. ImmunoGen, also based in the US, specializes in chemotherapy drug development.
View the full chemotherapy market report:
https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Partnerships and Innovations Creating Growth Opportunities in Chemotherapy
Key players in the chemotherapy market are increasingly collaborating through strategic partnerships to accelerate the commercialization of cutting-edge medical devices that support chemotherapy delivery and patient care. These alliances leverage combined expertise to drive innovation, improve treatment outcomes, and meet unmet clinical needs. For example, in March 2023, EVERSANA, a US provider of life sciences services, partnered with ChemoMouthpiece LLC, a US medical device company, to support the launch of the Chemo Mouthpiece across the United States. This device is an intraoral ice pack used to deliver cryotherapy to patients undergoing chemotherapy, helping to prevent and treat oral mucositis-one of the most painful side effects of chemotherapy.
Dominant Segments Within the Chemotherapy Market
The chemotherapy market is classified across several categories, including:
1) Product Type - featuring pumps, cannulas, catheters, and other related products
2) Service - covering blood cancer, throat cancer, lung cancer, ovarian cancer, and stomach cancer
3) Drugs - including alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, among others
4) Route of Administration - oral and intravenous
5) End User - hospitals, research institutes, and other users
Further breakdown includes:
- Pumps subdivided into infusion pumps, portable pumps, and ambulatory pumps
- Cannulas categorized as peripheral cannulas, central venous catheters, and implantable ports
- Catheters classified as chemotherapy catheters and PICC lines
- Other products including safety devices, IV sets, and administration sets
This detailed segmentation highlights the broad scope of the chemotherapy market and its diverse range of products, applications, and users, underscoring the complexity and potential of this expanding healthcare space.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Examination of Segments, Industry Trends, and Key Players in the Chemotherapy Market here
News-ID: 4496709 • Views: …
More Releases from The Business Research Company
Top Companies and the Competitive Environment in the Cancer Supportive Care Drug …
The cancer supportive care drugs market is poised for steady expansion as the global healthcare landscape evolves. With advances in oncology and a growing focus on improving patient quality of life, this sector is expected to witness significant developments through 2030. Let's explore the market's size projections, key drivers, leading companies, emerging trends, and segmentation to understand the opportunities ahead.
Projected Growth and Market Size of Cancer Supportive Care Drugs by…
Analysis of Segmentation, Market Dynamics, and Competitive Landscape in the Canc …
The cancer clinical decision tools sector is poised for significant expansion as advances in technology and healthcare converge to improve cancer diagnosis and treatment planning. This market is set to evolve rapidly, driven by innovations in artificial intelligence and broader integration of clinical data, enhancing oncologists' ability to make informed decisions. Let's explore the market's growth trajectory, key players, emerging trends, and detailed segments shaping its future.
Projected Growth and Market…
Segment Evaluation and Major Growth Areas in the Charcot-Marie-Tooth Disease Mar …
The Charcot-Marie-Tooth disease market is gaining significant attention as advancements in medical research and treatment options continue to evolve rapidly. With breakthroughs in gene therapy and precision medicine, this field is positioned for substantial growth over the next decade. Let's explore the current market size, key players, emerging trends, and detailed segment analysis shaping the future of this rare neurological disorder market.
Projected Market Size and Growth Trajectory of the Charcot-Marie-Tooth…
Emerging Sub-Segments Transforming the Calcium Gluconate Market Landscape
The calcium gluconate market is on a promising growth trajectory, fueled by rising health awareness and increased medical applications. As demand for supplements and advanced formulations grows, this sector is set to experience significant expansion, driven by innovations and demographic shifts worldwide. Let's explore the market size, key players, trends, and segment breakdowns shaping this industry's future.
Calcium Gluconate Market Size and Its Growth Outlook by 2030
The calcium gluconate…
More Releases for Chemo
Liposomal Doxorubicin Market 2025-2033: FDA-Approved in Cancer Treatment: Safer …
The Global Liposomal Doxorubicin Market reached US$ 1.33 billion in 2024 and is expected to reach US$ 2.23 billion by 2033, growing at a CAGR of 6.1% during the forecast period 2025-2033.
Liposomal Doxorubicin Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of…
Marine Chemicals Market Growth in Future Scope 2025-2032 | Total Group, Aqua Mar …
The global marine chemicals market is estimated to be valued at USD 4.55 Bn in 2025 and is expected to reach USD 6.58 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.
The Marine Chemicals Market Report 2025 is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the…
Understanding Chemo Ports: Reliable access for medium- and long-term drug infusi …
What is a Chemo Port?
A chemo port [https://www.teamstandmedical.com/chemo-port-implantable-port-kit-product/]is a small, implanted medical device [https://www.teamstandmedical.com/products/] used for patients undergoing chemotherapy. It is designed to provide a long-term, reliable way to deliver chemotherapy drugs directly into a vein, minimizing the need for repeated needle insertions. The device is placed under the skin, usually in the chest or upper arm, and connects to a central vein, making it easier for healthcare providers…
Chemo-Aide Dispensing Pin Market to see Huge Growth by 2028
The Chemo-Aide Dispensing Pin Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). With distal connectors is a type of Chemo-Aide Dispensing Pin that has an attached extension tubing that enables the flow of medicine from the vial to the injection site. It allows for the infusion to be started at home or in the clinic, the infusion set is connected…
Chemo Pumps Market Size 2021 with Key Players Growth Opportunities and Forecast …
Latest released, the research study on Global Chemo Pumps Market Research Report 2021, report comprises growth rate, size, analysis by type, market segment by Application, market competition by manufacturers, share by region, manufacturing cost analysis, Also, the Chemo Pumps Market offers market breakdown, competitive situation and trends, key raw materials analysis, dynamics, forecast by type, by application and revenue estimates with covid-19 impact till 2027.
Get Free sample copy of the…
Fulvestrant Market Will Generate Record Revenue by 2027 Covid-19 Analysis | Chem …
This Fulvestrant market research works as the best evaluation tool to track the progress of the industry and keep an eye on the competitor’s growth strategies. It further helps to keep you ahead of your business competitors. This report depicts a few potential problems and gives solutions to them by doing comprehensive research on market scenario. Valuable information is provided here about particular market segment according to product type, application,…
